Laila S. Tabatabai VIEW CLINICAL PROFILE

Laila S. Tabatabai, MD

Associate Professor of Clinical Medicine, Academic Institute
Houston Methodist
Weill Cornell Medical College


VIEW CLINICAL PROFILE
Biography

Laila S. Tabatabai, MD is a board-certified endocrinologist with expertise in osteoporosis, fragility fractures and metabolic bone diseases.  Her postdoctoral training included a fellowship in endocrinology at Johns Hopkins Hospital, internship and residency in internal medicine at the University of Maryland Medical Center in Baltimore.  She received her medical degree, with distinction in research, at Albany Medical College in New York. 

Dr. Tabatabai is an Associate Professor of Clinical Medicine with the Houston Methodist Academic Institute and Weill Cornell Medical College.  She is a member of the Board of the Bone Health and Osteoporosis Foundation (BHOF), which is dedicated to patient advocacy and educational efforts for those affected by osteoporosis and bone diseases.  Dr. Tabatabai has presented at national meetings including the American Association of Clinical Endocrinologists (AACE), Endocrine Society, American Society of Bone and Mineral Research and the Endocrine Nurses Society Symposium. 

Description of Research

Dr. Tabatabai has been the recipient of numerous research grants in the area of osteoporosis and anabolic medications.  She has authored peer-reviewed publications appearing in the Journal of Clinical Endocrinology and Metabolism, Endocrine Practice and other journals.  She is considered an expert in the field of anabolic agents for treatment of fragility fractures in high-risk osteoporosis patients. 

Dr. Tabatabai is the Principle Investigator for the Disease Monitoring Program for burosumab, an anti-FGF23 monoclonal antibody which corrects phosphate homeostasis in individuals with X-linked hypophosphatemic rickets.  She has chaired the Endocrine Society’s CME and MOC-certified educational program on hypophosphatemia.

Active Clinical Trials

X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP)

NCT03651505

Publications

The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome
Sugarman, J, Maruri, A, Hamilton, DJ, Tabatabai, L, Luca, D, Cimms, T, Krolczyk, S, Roberts, MS & Carpenter, TO 2023, , Bone, vol. 166, 116598, pp. 116598. https://doi.org/10.1016/j.bone.2022.116598

Regression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling
Motlaghzadeh, Y, Tabatabai, LS, Longo, E & Sellmeyer, DE 2022, , Osteoporosis International, vol. 33, no. 11, pp. 2449-2452. https://doi.org/10.1007/s00198-022-06501-z

Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review
Bosetti, R, Tabatabai, L, Naufal, G, Menser, T & Kash, B 2021, , PLoS ONE, vol. 16, no. 11 November, e0260139. https://doi.org/10.1371/journal.pone.0260139

Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review
Bosetti, R, Tabatabai, L, Naufal, G, Menser, T & Kash, B 2021, , PLoS ONE, vol. 16, no. 11 November, e0260139, pp. e0260139. https://doi.org/10.1371/journal.pone.0260139

Nutritional Supplements and Skeletal Health
Tabatabai, LS & Sellmeyer, DE 2021, , Current Osteoporosis Reports, vol. 19, no. 1, pp. 23-33. https://doi.org/10.1007/s11914-020-00651-x

New model of integrated care for uncontrolled type 2 diabetes in a retrospective, underserved adult population in the USA: A study protocol for an effectiveness and cost-effectiveness analysis
Bosetti, R, Tabatabai, L, Naufal, G, Brito, R & Kash, B 2020, , BMJ open, vol. 10, no. 7, e038084, pp. e038084. https://doi.org/10.1136/bmjopen-2020-038084

PDB117 A NEW MODEL OF INTEGRATED CARE FOR COMPLEX TYPE 2 DIABETES IN UNDERSERVED POPULATIONS: A STUDY PROTOCOL FOR A COST-EFFECTIVENESS ANALYSIS
Bosetti, R, Tabatabai, L, Naufal, G, Brito, R & Kash, B 2019, , Value in Health, vol. 22, pp. S159. https://doi.org/10.1016/j.jval.2019.04.664

A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer
Tabatabai, LS, Bloom, J, Stewart, S & Sellmeyer, DE 2019, , Journal of Womens Health, vol. 28, no. 1, pp. 87-92. https://doi.org/10.1089/jwh.2017.6863

Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure
Osuna, PM, Brown, SJ, Tabatabai, LS & Hamilton, DJ 2018, , Methodist DeBakey cardiovascular journal, vol. 14, no. 4, pp. 257-265. https://doi.org/10.14797/mdcj-14-4-257

Hypothyroidism and the Heart
Udovcic, M, Pena, RH, Patham, B, Tabatabai, L & Kansara, A 2017, , Methodist DeBakey cardiovascular journal, vol. 13, no. 2, pp. 55-59. https://doi.org/10.14797/mdcj-13-2-55

The Parathyroid Gland and Heart Disease
Brown, SJ, Ruppe, MD & Tabatabai, LS 2017, , Methodist DeBakey cardiovascular journal, vol. 13, no. 2, pp. 49-54. https://doi.org/10.14797/mdcj-13-2-49

FRACTURE LIAISON SERVICES: MULTIDISCIPLINARY APPROACHES TO SECONDARY FRACTURE PREVENTION
Osuna, PM, Ruppe, MD & Tabatabai, LS 2017, , Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 23, no. 2, pp. 199-206. https://doi.org/10.4158/EP161433.RA

FSH levels predict bone loss in premenopausal women treated for breast cancer more than one year after treatment
Tabatabai, LS, Bloom, J, Stewart, S & Sellmeyer, DE 2016, , Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 3, pp. 1257-1262. https://doi.org/10.1210/jc.2015-3149

Addressing Barriers to Secondary Fracture Prevention
Tabatabai, LS & Petak, SM 2016, , Journal of Clinical Densitometry, vol. 19, no. 1, pp. 3-4. https://doi.org/10.1016/j.jocd.2015.07.002

Arterialized venous bicarbonate is associated with lower bone mineral density and an increased rate of bone loss in older men and women
Tabatabai, LS, Cummings, SR, Tylavsky, FA, Bauer, DC, Cauley, JA, Kritchevsky, SB, Newman, A, Simonsick, EM, Harris, TB, Sebastian, A & Sellmeyer, DE 2015, , Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 4, pp. 1343-1349. https://doi.org/10.1210/jc.2014-4166

Other Secondary Hyperparathyroid States
Tabatabai, L & Jan De Beur, SM 2015, . in The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier, pp. 671-684. https://doi.org/10.1016/B978-0-12-397166-1.00046-1

Carotid endarterectomy in the elderly: Does gender effect outcome?
Ozsvath, KJ, Darling, RC, Tabatabai, L, Roddy, SP, Paty, PSK, Chang, BB, Kreienberg, PB, Mehta, M & Shah, DM 2002, , Cardiovascular Surgery, vol. 10, no. 6, pp. 534-537. https://doi.org/10.1016/S0967-2109(02)00054-6

Carotid endarterectomy in the elderly: Does gender effect outcome?
Ozsvath, KJ, Darling, RC, Tabatabai, L, Roddy, SP, Paty, PSK, Chang, BB, Kreienberg, PB, Mehta, M & Shah, DM 2002, Cardiovascular Surgery, vol 10, no. 6, pp. 534-537. DOI: 10.1016/S0967-2109(02)00054-6

VIEW FULL PUBLICATIONS